Академический Документы
Профессиональный Документы
Культура Документы
Troubleshooting
Page 1
Page 3
A. Pressure
B. Peak shape
C. Retention
Page 4
Pressure Issues
Column Observations
Potential Problems
High pressure
- Plugged frit
- Column contamination
- Plugged packing
Low Pressure
- Leak
- Flow Incorrect
Page 5
Column Cleaning
Flush with stronger solvents than your mobile
phase.
Reversed-Phase Solvent Choices
in Order of Increasing Strength
Must Reverse
to
Re-Equilibrate
*Tip: When using either Hexane or Methylene Chloride the column must be flushed
with Isopropanol before returning to your reversed-phase mobile phase.
Page 7
Compression
Ferrule
Wear gloves
Do not allow bed to dry
Do not touch the column body heat will extrude packing
Column Body
Do not overtighten
The Trick:
Prevention Techniques - A Better Choice!
Use column protection
- In-line filters
- Guard columns
Easy
Filter samples
Filter buffered mobile phases
Sample clean-up (i.e. SPE)
Appropriate column flushing
Not As Easy
Page 9
Page 10
1.
Split peaks
2. Peak tailing
3. Broad peaks
Many peak shape issues are also combinations - i.e. broad and tailing
or tailing with increased retention
Symptoms do not necessarily affect all peaks in the chromatogram
Each of these problems can have multiple causes
Page 11
Normal
Double
Peaks
Injection 1
After Column Wash
with 100% ACN
Injection 30
Injection 1
4
1
1
4
1
4
Time (min)
10
15
Time (min)
10
15
Time (min)
10
15
Tip: Column washing eliminates the peak splitting, which resulted from a contaminant on the column
How could this be prevented? (Guard Column, SPE clean up of samples, Periodic column wash)
Page 13
A. Injection Solvent
100% Acetonitrile
B. Injection Solvent
Mobile Phase
2
2
1
10
Time (min)
10
Time (min)
Tip: Injecting in a solvent stronger than the mobile phase can cause peak shape
problems such as peak splitting or broadening
Trick: Keep Organic Concentration in Sample Solvent < Mobile Phase
Page 14
Group/Presentation Title
Agilent Restricted
September 10, 2008Month
##, 200X
Page 15
Normal
Tailing
Tailing
Page 16
Peak Tailing
1
3
2
No TEA
USP TF (5%)
1. 1.29
2. 1.91
3. 1.63
4. 2.35
5. 1.57
0.0
10 mM TEA
USP TF (5%)
4
5
2.5
1.
2.
3.
4.
5.
5.0
0.0
2.5
1.19
1.18
1.20
1.26
1.14
5.0
Time (min)
TIme (min)
Tip: Mobile phase modifier (TEA) competes with Sample for surface ion exchange
sites at mid-range pH values
Page 17
Peak Tailing
1
1
2
pH 3.0
USP TF (5%)
pH 7.0
USP TF (5%)
4
5
4. 1.33
4. 2.35
4
0.0
2.5
5.0
Time (min)
0.0
2.5
5.0
Time (min)
Tip: Reducing mobile phase pH reduces interactions with silanols and peak tailing.
Page 18
Peak Tailing
Amines
Column: ZORBAX Extend-C18, 4.6 x 150 mm, 5 m m Mobile Phase: See Below
Flow Rate: 1.0 mL/min Temperature: RT
Detection: UV 254 nm
Sample: 1. Maleate 2. Scopolamine 3. Pseudoephedrine 4. Doxylamine 5. Chlorpheniramine 6. Triprolidine 7. Diphenhydramine
pH 7
30% 20 mM Na2HPO4
70% MeOH
pH 11
30% 20 mM TEA
70% MeOH
7
2,3
3
tR = 8.5
tR = 11.4
5
2
5
Time (min)
Time (min)
10
QC test forward
direction
Plates
1.
2.
3.
4
7629
12043
13727
13355
TF
2.08
1.64
1.69
1.32
Plates
TF
3
1.
2.
3.
4
7906
12443
17999
17098
1.
2.
3.
4
1.43
1.21
1.19
1.25
2.5
Time (min)
TF
1.06
1.21
1.11
1.17
4
4
0.0
7448
12237
15366
19067
5.0
0.0
2.5
Time (min)
5.0
0.0
2.5
Time (min)
5.0
Page 20
10
mAU
1500
1000
500
0
0
10
15
20
25
Time (min)
Normal
Fronting
Symmetry < 0.9
Causes:
Column Overload
Page 21
Peak Tailing/Broadening
Sample Load Effects
Columns: 4.6 x 150 mm, 5m
Mobile Phase: 40% 25 mM Na2HPO4 pH 7.0 : 60% ACN
Flow Rate: 1.5 mL/min
Temperature: 40C
Sample: 1. Desipramine 2. Nortriptyline 3. Doxepin 4. Imipramine 5. Amitriptyline 6. Trimipramine
Tailing
Eclpse XDB-C8
USP TF (5%) i
1.
2.
3.
4.
5.
6.
A
1.60
2.00
1.56
2.13
2.15
1.25
B
1.70
1.90
1.56
1.70
1.86
1.25
High Load
x10
A.
Broadening
Competitive C8
Plates
C.
5
Time (min)
B.
10
5
Time (min)
10
Low Load D.
5
Time (min)
1.
2.
3.
4.
5.
6.
850
815
2776
2539
2735
5189
5941
7842
6231
8359
10022
10725
5
Time (min)
Group/Presentation Title
Agilent Restricted
September 10, 2008Month
##, 200X
11
Page 23
Sample 2 : Chlorpheniramine
maleate
and Pseudoephedrine
Peak 1: maleate
Peak 2: pseudoephedrine
Peak 3: chlorpheniramine (from 1st
injection)
Plates
1. 5922
2. 9879
3. 779
5
Time (min)
10
Time (min)
10
15
Tip: The extremely low plates for moderately retained peaks are an indication of a
very late eluting peak from a preceding run.
Page 24
12
Extra-Column Dispersion
Use short, small internal diameter tubing between the injector and
the column and between the column and the detector.
Make certain all tubing connections are made with matched
fittings.
Use a low-volume detector cell.
Inject small sample volumes.
Page 25
Peak Broadening
Extra-Column Volume
Column: StableBond SB-C18, 4.6 x 30 mm, 3.5 m
Mobile Phase: 85% H2O with 0.1% TFA : 15% ACN
Flow Rate: 1.0 mL/min
Temperature: 35C
Sample: 1. Phenylalanine 2. 5-benzyl-3,6-dioxo-2-piperazine acetic acid 3. Asp-phe 4. Aspartame
10 mL extra-column
volume
50 mL extra-column
volume (tubing)
2
4
4
0.0
0.5
1.0
1.5
Time (min)
2.0
0.0
0.5
1.0
1.5
Time (min)
2.0
Page 26
13
Page 27
Waters
Swagelok
0.130
in.
0.090
in.
Rheodyne
Parker
0.170
in.
0.090
in.
Valco
Uptight
0.080
in.
0.090
in.
Page 28
14
Mixing Chamber
X
If Dimension X is too short, a dead-volume,
or mixing chamber, will occur
Page 29
PolyKetone
Easy, hand tighten column connection
600 bar Pressure Rating PN: 5042-8957 (10/pk)
Fits to SS Tubing
Page 30
15
Page 31
Column 1 - Initial
5
9
Time (min)
12
15
5
9
Time (min)
12
15
Page 32
Group/Presentation Title
Agilent Restricted
September 10, 2008Month
##, 200X
16
OH
M +2
Salicylaldehyde
M +2
O
H
M +2
: :
N:
OH
8-hydroxyquinoline
5-membered ring complex
: : :
: : : :
M +2
OH
a-benzoinoxomine
5-membered ring complex
Page 33
OH
OH
1.
2.
OH
Tf: 3.7
OH
OH
1.
2.
OH
Tf: 1.2
17
Column 1
4
Time (min)
Column 2
Column 2 - Fresh
mobile phase
3 4 5
Time (min)
4
Time (min)
I have experimented with our mobile phase, opening new bottles of all mobile phase
components. When I use all fresh ingredients, the problem ceases to exist, and I
have narrowed the problem to either a bad bottle of TEA or phosphoric acid. Our
problem has been solved.
Group/Presentation Title
Agilent Restricted
September 10, 2008Month
##, 200X
Page 35
VD = 0.43 mL
Column:
10
20
30
A: 5/95 methanol/ 25 mM
phosphate
pH 2.50
B: 80/20 methanol/25 mM
phosphate
pH 2.50
40
Flow Rate:
0.5 mL/min
Temperature: 25C
VD = 2.0 mL
Injection:
5 L
Detection:
250 nm
Sample:
10
20
30
40
Page 36
18
001014P1.PPT
Page 37
Buffers
Resist Changes in pH and Maintain Retention
Improve Peak Shape for Ionizable Compounds
Page 38
19
Evaluate:
All causes of column-to-column change*
Method ruggedness (buffers/ionic strength)
pH sensitivity (sample/column interactions)
Page 39
pH 4.5 - Lot 1
1
2-Base
3
4-Base
8
10 12
Time (min)
14
16
18
8
10 12
Time (min)
14
16
18
pH 3.0 - Lot 2
pH 4.5 - Lot 2
1
2-Base
1
3
4-Base
4
0
8
10 12
Time (min)
14
16
18
8
10 12
Time (min)
14
16
18
Page 40
Group/Presentation Title
Agilent Restricted
September 10, 2008Month
##, 200X
20
RCOOH
RCOO- +
[RCOO-][H+]
H+
Ka =
COOH
[RCOOH]
COO
Ka = 6.4 x 10-5
pKa = 4.2
H+
At pH 4.2 the sample exists as benzoic acid and the benzoate ion in a ratio
of 1:1. Peak shape can be poor
At pH 5.2 91% of the sample exists as the benzoate ion. RP retention decreases.
At pH 3.2 91% of the sample exists as benzoic acid. RP retention increases.
Page 41
pH 4.4
pH 3.0
CH2CH(CH3)2
Ibuprofen
pKa = 4.4
4
5
6
Time (min)
10
4
5
6
Time (min)
10
Inconsistent and tailing peaks may occur when operating close to an analyte
pKa and should be avoided.
Page 42
21
R3NH+
R3N
H+
[R3N][H+]
Ka =
+
H
CH
CHOCH CH N
2
CHOCH CH N
CH
Ka = 1 x 10-9
pKa = 9
CH
CH
[R3NH+]
H+
Page 43
SCD
Column: mBondapak-C18
Mobile Phase: 60% 25 mM phosphate buffer
40% Methanol
5
1. Salicylic acid
2. Phenobarbital
3. Phenacetin
4. Nicotine
5. Methamphetamine
30
1.0
0.5
5
4 SOC
3 C
2 + 12-OC +
1
Retention
log k
UDC
7,12 - OC
0.0
20
J.C. 268(1983) 1
10
10
1
2
+
-0.5
8 pH
ELUENT pH
22
Page 45
Column:
StableBond SB-C18, 4.6 x 150
mm, 5 mm
Mobile Phase:
45% 25 mM
NaH2PO4, pH 3.0
55% MeOH
Flow Rate: 2.0 mL/min.
Temperature:35C
Detection:
UV 254 nm
Sample:
Cardiac Drugs
1. Diltiazem
2. Dipyridamole
3. Nifedipine
5
4. Lidoflazine
5. Flunarizine
3
4
6
7
Time (min)
10
11
12
13
14
Page 46
23
StableBond SB-C18
4.6 x 150 mm, 5 mm
Mobile Phase:
A: 20% H2O
B: 80% MeOH
Flow Rate: 1.0 mL/min.
Temperature:35C
UV Detection:
254 nm
Sample:
Cardiac Drugs
10
15
20
25
Time (min)
Buffers are critical to good retention and peak shape in many separations.
Page 47
Columns:
Unsuitable Peak
StableBond SB-C18
4.6 x 150 mm, 5 mm
Mobile Phase:
A: 30% 25 mM NaH2PO4, pH
4.8 unbuffered
B: 70% MeOH
Flow Rate: 1.0 mL/min.
Temperature:35C
UV Detection:
254 nm
Sample:
Cardiac Drugs
1. Diltiazem
2. Dipyridamole
Shape
3. Nifedipine
4. Lidoflazine
5. Flunarizine
5
10
15
20
25
Time (min)
Page 48
24
Purge Solvent:
50% methanol/water with
1.0% TFA
Solute: Toluene
Kirkland, J.J. and J.W. Henderson, Journal of Chromatographic Science, 32 (1994) 473-480.
Page 49
000023P1.PPT
Initial
After 30 injections
25
Detection Issues
Page 51
Normal
Negative
Causes:
Absorbance of sample is less than the mobile phase.
Equilibrium disturbance when sample solvent passes through the
column.
Normal with Refractive Index Detectors.
Page 52
26
Ghost Peaks
60
15
30
15
0
3
20% - 100%
MeOH Gradient
No Sample Injected
15
17
Page 53
Noisy Baselines
Time
(min.)
Possible Causes:
Dirty Flow Cell
Detector Lamp Failing
Pulses from Pump if Periodic
Temperature Effects on Detector
Air Bubbles passing through Detector
Page 54
27
Drifting Baselines
Gradient Elution
Temperature Unstable (Refractive Index Detector)
Contamination in Mobile Phase
Mobile Phase Not in Equilibrium with Column
Contamination Bleed in System
Page 55
28
OEM Lamp
Peak 1
S/N = 150
Peak 2
S/N = 400
Peak 3
S/N = 300
Peak 1
S/N = 15
Peak 2
S/N = 50
Peak 3
S/N = 50
0.2 sec
Column:
Poroshell 300SB-C18
2.1 x 75 mm, 5 mm
Mobile Phase:
A: 95% H2O, 5% ACN with 0.1% TFA
B: 5% H2O, 5% ACN with 0.1% TFA
0.5 sec
1st peak = 1.2 sec
At 5 pts/sec = 6 pts
Flow Rate:
1.0 sec
Detector:
0.1
0.2
0.3
0.4
0.5
Time (min)
0.6
0.7
0.8
UV 215 nm
Piston stroke:
2.0 sec
0
2 mL/min
Temperature:70C
0.9
1.0
20
Sample:
1. Neurotensin3. Lysozyme
2. RNaseA 4. Myoglobin
Tip: Adjust the response rate of your detector for best peak detection.
Page 58
29
Conclusions
HPLC column problems are evident as
High pressure (prevention better than the cure)
Undesirable peak shape
Changes in retention/selectivity
Often these problems are not associated with the column and
may be caused by instrument and chemistry issues.
pH of mobile Phase
Instrument Connections
Detector Settings
Metal Contamination
Start With the Correct Questions
Find the Answers
The Answers will Lead to Solutions
Page 59
30